# NoToVir Srl jobs and careers

> 0 open roles at NoToVir Srl as of October 23, 2026. Source: https://www.thejobsmap.com/company/notovir-srl

NoToVir is an Italian biotechnology company focused on the development of innovative therapies for HPV-related cancers. Our lead asset, Selisistat, is a first-in-class SIRT1 inhibitor with potential as a targeted radiosensitizer and chemosensitizer. We aim to address a major unmet medical need by restoring tumor suppressor activity in HPV-driven malignancies through a precision oncology approach. Our development strategy begins with HPV-positive head and neck cancer, with plans to expand across multiple indications where a shared molecular mechanism supports a built-in pipeline. NoToVir is backed by a multidisciplinary team of scientists, clinicians, regulatory experts, and business advisors with strong experience in oncology drug development. We are currently preparing a Phase IIb clinical trial and are actively engaging with investors and partners to accelerate Selisistat’s path to market.

## Key facts

| | |
|---|---|
| Open roles | 0 |
| Headquarters | Italy |
| Founded | 2017 |
| Employees | 1 to 10 |
| Industries | Biotechnology, Health Diagnostics, Medical |
| Website | https://notovir.com |

## Leadership

- Marco De Andrea, Chief Technology Officer

## Common questions

### Is NoToVir Srl hiring right now?

NoToVir Srl has no open roles listed as of October 23, 2026. Roles appear here as soon as they are posted on NoToVir Srl's careers site.

### Where is NoToVir Srl headquartered?

NoToVir Srl is headquartered in Italy and was founded in 2017.

### Who leads NoToVir Srl?

Marco De Andrea, Chief Technology Officer, is at the top of NoToVir Srl's org chart.

### How do I apply for a job at NoToVir Srl?

Pick a role on NoToVir Srl's TheJobsMap page and select Apply. Every listing links to the original posting on NoToVir Srl's own careers site, so you apply directly with the employer.